Beximco Pharmaceuticals Limited reported a rise in its Q3 pretax profit.
Its revenue for the quarter rose to Tk2.43 million, from Tk2.15 million, in the year-ago period. Its pretax profit climbed to Tk580,836, from Tk513,597, while EPS gained to Tk1.38, from Tk1.30.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in